Fora Capital, LLC Argenx Se Transaction History

Fora Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	BUY	$356.95 - $413.29 $1.84 Million - $2.12 Million	5,141 New	5,141 $2.02 Million
Q2 2021 Aug 16, 2021	SELL	$257.11 - $319.92 $700,367 - $871,462	-2,724 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$268.3 - $380.31 $730,849 - $1.04 Million	2,724 New	2,724 $750 Million
Q3 2020 Nov 13, 2020	SELL	$215.51 - $272.51 $473,475 - $598,704	-2,197 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$127.44 - $232.72 $279,985 - $511,285	2,197 New	2,197 $495 Million

400

30.9M

376K

489K

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $34.8B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.